Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Shaare Zedek Medical Center.
Recruitment status was  Recruiting
Study NCT00716898   Information provided by Shaare Zedek Medical Center

First Received on July 9, 2008.   Last Updated on May 29, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Thrombosis
Angina Pectoris
Advanced Solid Malignancy
Additional conditions recognized in this trial
Angina, Unstable
Neoplasms
More general conditions related to this trial
Cardiovascular Diseases
Chest Pain
Embolism and Thrombosis
Heart Diseases
Myocardial Ischemia
Pain
Signs and Symptoms
Vascular Diseases
Additional drug interventions recognized in this trial
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Shaare Zedek Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services